Clinical Trials Directory

Trials / Conditions / Adult Angiosarcoma

Adult Angiosarcoma

9 registered clinical trials studyying Adult Angiosarcoma.

StatusTrialSponsorPhase
CompletedDaily Oral Regorafenib for Chemotherapy-Refractory, Metastatic and Locally Advanced Angiosarcoma
NCT02048722
Northwestern UniversityPhase 2
CompletedTrebananib in Treating Patients With Advanced Angiosarcoma That Cannot Be Removed by Surgery
NCT01623869
National Cancer Institute (NCI)Phase 2
CompletedGemcitabine With or Without Pazopanib in Treating Patients With Refractory Soft Tissue Sarcoma
NCT01532687
OHSU Knight Cancer InstitutePhase 2
CompletedPazopanib Hydrochloride in Treating Patients With Advanced Angiosarcoma
NCT01462630
Fox Chase Cancer CenterPhase 2
CompletedVismodegib and Gamma-Secretase/Notch Signalling Pathway Inhibitor RO4929097 in Treating Patients With Advanced
NCT01154452
National Cancer Institute (NCI)Phase 1 / Phase 2
CompletedCixutumumab and Doxorubicin Hydrochloride in Treating Patients With Unresectable, Locally Advanced, or Metasta
NCT00720174
National Cancer Institute (NCI)Phase 1
CompletedObservation, Radiation Therapy, Combination Chemotherapy, and/or Surgery in Treating Young Patients With Soft
NCT00346164
Children's Oncology GroupPhase 3
CompletedSorafenib in Treating Patients With Metastatic, Locally Advanced, or Recurrent Sarcoma
NCT00245102
National Cancer Institute (NCI)Phase 2
CompletedDepsipeptide (Romidepsin) in Treating Patients With Metastatic or Unresectable Soft Tissue Sarcoma
NCT00112463
National Cancer Institute (NCI)Phase 2